Sizeable differences in gene expression means and ratios—based ... and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's ...

The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.

According to clinical guidelines, high-risk myeloma patients should receive intensified treatment regimens. However, heterogeneity in clinical markers and staging systems lead to various interpretatio ...

MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines. ROCKVILLE, Md.

Telomir Pharma’s Telomir-1 shows dose-dependent restoration of neurological, liver & kidney functions in preclinical for Wilson’s disease: Miami, Florida Saturday, June 14, 20 ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...

MaxCyte, a Rockville, Maryland-based cell engineering technology company, said its Flow Electroporation technology, which is already used in over 19 clinical and commercial programs, will be paired ...